ATH
Click for more information
0.00% 0.5¢ alterity therapeutics limited

Ann: FDA End-of Phase 2 Status Update, page-2

  1. Pixie
    7,425 Posts.
    lightbulb Created with Sketch. 125
    clock Created with Sketch.
    13/02/15
    09:50
    Post #: 14748093
    We can move forward...Alleluja!

    Repeat toxicology animal studies with higher dose - that is quick and easy OR additional safety during PH3....can do also...

    lets get on with it!
    PBT Price at posting: 20.5¢ Sentiment: Hold Disclosure: Held
    Likes Created with Sketch. 1  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
TX3 Canadian fieldwork yields multiple pegmatites for Trinex
right-arrow Created with Sketch.
RNU Renascor wins a funding boost given it wants to produce a critical mineral – but $5M award pales in comparison to some
right-arrow Created with Sketch.
AUG Augustus sees imperial share rise on high-grade Cu and gold results at Ti-Tree
right-arrow Created with Sketch.
IMM Immutep reports strong response rate from immunotherapies treating carcinomas
right-arrow Created with Sketch.
GED Golden Deeps eyes prospective Cu-Au tenements in NSW with HOA
right-arrow Created with Sketch.
watchlist Created with Sketch. Add ATH (ASX) to my watchlist
(20min delay)
Last
0.5¢ 		Change
0.000(0.00%) 		Mkt cap ! $26.22M
Open High Low Value Volume
0.5¢ 0.5¢ 0.5¢ $8.75K 1.75M

Buyers (Bids)

No. Vol. Price($)
59 63306661 0.4¢
 

Sellers (Offers)

Price($) Vol. No.
0.5¢ 28430837 21
View Market Depth
Last trade - 16.10pm 12/07/2024 (20 minute delay) ?
ATH (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.